ctrl K

AI Score

Unlock

ArriVent BioPharma Inc. C... (AVBP)

AI Score

Unlock

18.82

0.25 (1.35%)

At close: Mar 28, 2025, 2:05 PM

ArriVent BioPharma Common Stock Balance Sheet Statement

Table Mode

Year	FY24	FY23	FY22	FY21
Cash & Equivalents	74.29M	150.39M	163.37M	37.28M
Short-Term Investments	144.57M	n/a	n/a	n/a
Long-Term Investments	47.68M	n/a	n/a	2K
Other Long-Term Assets	126K	2.84M	72K	87K
Receivables	500K	761K	500K	250K
Inventory	n/a	-240K	n/a	n/a
Other Current Assets	7.62M	9.06M	156K	29K
Total Current Assets	226.98M	159.97M	182.62M	42.95M
Property-Plant & Equipment	154K	291K	139K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	47.96M	3.13M	211K	89K
Total Assets	274.94M	163.1M	182.83M	43.04M
Account Payables	3.78M	4.53M	3.09M	293K
Deferred Revenue	n/a	n/a	-1	n/a
Short-Term Debt	162K	140K	128K	n/a
Other Current Liabilities	13.33M	6.95M	5.14M	1.52M
Total Current Liabilities	17.27M	11.62M	8.36M	1.82M
Long-Term Debt	14K	177K	11K	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	14K	177K	11K	n/a
Total Liabilities	17.29M	11.8M	8.37M	1.82M
Total Debt	176K	317K	139K	n/a
Common Stock	3K	n/a	4K	4K
Retained Earnings	-238.33M	-157.84M	-88.51M	-51.61M
Comprehensive Income	-211K	n/a	-4K	-4K
Shareholders Equity	257.65M	151.3M	174.46M	41.22M
Total Investments	192.25M	n/a	n/a	2K